Peter Held
Impact in
-
- Heart Failure Treatment and Management
- Cardiovascular Function and Risk Factors
- Blood Pressure and Hypertension Studies
- Cardiac pacing and defibrillation studies
- Renin-Angiotensin System Studies
- Cardiac electrophysiology and arrhythmias
-
- Hormonal Regulation and Hypertension
Papers in
-
- Heart Failure Treatment and Management 11
- Antiplatelet Therapy and Cardiovascular Diseases 6
- Cardiovascular Function and Risk Factors 4
- Cardiac electrophysiology and arrhythmias 4
- Atrial Fibrillation Management and Outcomes 4
- Cardiac pacing and defibrillation studies 2
- Surgery 15
- Peripheral Artery Disease Management 11
- Co-authors
- Salim Yusuf (12 shared papers)Karl B Swedberg (9 shared papers)John J.V. McMurray (8 shared papers)Bertil Olofsson (7 shared papers)Jan Östergren (7 shared papers)Eric L. Michelson (6 shared papers)Marc Alan Pfeffer (5 shared papers)Christopher Bull Granger (5 shared papers)
- Journals
- The Lancet (5 papers)American Heart Journal (4 papers)European Heart Journal (3 papers)The American Journal of Cardiology (3 papers)British Journal of Clinical Pharmacology (2 papers)
- Partner nations
- SwedenUnited StatesUnited Kingdom
In The Last Decade
Peter Held
40 papers receiving 10.2k citations
Peter Held's Hit Papers
Peers
Comparison fields: 5 of 123
- Cardiology and Cardiovascular Medicine 8.4k
- Endocrinology, Diabetes and Metabolism 1.9k
- Internal Medicine 195
- Family Practice 69
- Surgery 1.4k
Countries citing papers authored by Peter Held
This map shows the geographic impact of Peter Held's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Held with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Held more than expected).
Fields of papers citing papers by Peter Held
This network shows the impact of papers produced by Peter Held. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Held. The network helps show where Peter Held may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Held, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial Hit paper breakdown → | 2003 | 2364 |
| 2 | Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial Hit paper breakdown → | 2003 | 2025 |
| 3 | Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme Hit paper breakdown → | 2003 | 1497 |
| 4 | Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial Hit paper breakdown → | 2003 | 1311 |
| 5 | CHARM IN-VESTIGATORS AND COMMITTEES. EFFECTS OF CANDESARTAN IN PATIENTS WITH CHRONIC HEART FAILURE AND REDUCED LEFT-VENTRICULAR SYSTOLIC FUNCTION TAKING ANGIOTENSIN-CONVERTING-ENZYME INHIBITORS: THE CHARM-ADDED TRIAL Hit paper breakdown → | 2003 | 898 |
| 6 | Effects of the Early Administration of Enalapril on Mortality in Patients with Acute Myocardial Infarction Hit paper breakdown → | 1992 | 771 |
| 7 | Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease Hit paper breakdown → | 2016 | 472 |
| 8 | 1999 | 250 | |
| 9 | 1991 | 212 | |
| 10 | 2003 | 119 | |
| 11 | Routine medical management of acute myocardial infarction. Lessons from overviews of recent randomized controlled trials. | 1990 | 118 |
| 12 | 2016 | 104 | |
| 13 | 1985 | 98 | |
| 14 | 2008 | 97 | |
| 15 | 1992 | 91 | |
| 16 | 2019 | 91 | |
| 17 | 1999 | 82 | |
| 18 | 2018 | 82 | |
| 19 | 1990 | 81 | |
| 20 | 2018 | 75 |
About Peter Held
Peter Held is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Internal Medicine, Pharmacology and Family Practice, having authored 40 papers that have together received 11.2k indexed citations. Recurring topics across this work include Peripheral Artery Disease Management (11 papers), Heart Failure Treatment and Management (11 papers), Antiplatelet Therapy and Cardiovascular Diseases (6 papers), Cardiovascular Function and Risk Factors (4 papers), Cardiac electrophysiology and arrhythmias (4 papers), Venous Thromboembolism Diagnosis and Management (4 papers), Atrial Fibrillation Management and Outcomes (4 papers) and Cardiac pacing and defibrillation studies (2 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (8.4k citations), Endocrinology, Diabetes and Metabolism (1.9k citations), Internal Medicine (195 citations), Family Practice (69 citations) and Surgery (1.4k citations). Peter Held has collaborated with scholars based in Sweden, United States and United Kingdom. Frequent co-authors include Salim Yusuf, Karl B Swedberg, John J.V. McMurray, Bertil Olofsson, Jan Östergren, Eric L. Michelson, Marc Alan Pfeffer, Christopher Bull Granger, Chris B. Granger and Hans Wedel. Their work appears in journals such as The Lancet, American Heart Journal, European Heart Journal, The American Journal of Cardiology and British Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.